Results 11 to 20 of about 1,707,239 (310)

Barriers to immune cell infiltration in tumors

open access: yesJournal for ImmunoTherapy of Cancer, 2023
Increased immune cell infiltration into tumors is associated with improved patient survival and predicts response to immune therapies. Thus, identification of factors that determine the extent of immune infiltration is crucial, so that methods to ...
Craig L Slingluff   +3 more
doaj   +5 more sources

Immune infiltration and prostate cancer [PDF]

open access: yesFrontiers in Oncology, 2015
It is becoming increasingly clear that inflammation influences prostate cancer development and that immune cells are among the primary drivers of this effect.
Amy eStrasner, Michael eKarin
doaj   +5 more sources

Immune infiltration in aggressive papillary craniopharyngioma: High infiltration but low action

open access: yesFrontiers in Immunology, 2022
Papillary craniopharyngiomas (PCPs) are biologically benign but clinically aggressive lesions hence affect the quality of life. The expression of inflammatory mediators and regulation of the immune microenvironment in PCPs have not been investigated much.
Yanfei Jia   +10 more
doaj   +3 more sources

Roles of pyroptosis and immune infiltration in aortic dissection

open access: yesFrontiers in Molecular Biosciences
Introduction: Aortic dissection (AD) is often fatal, and its pathogenesis involves immune infiltration and pyroptosis, though the molecular pathways connecting these processes remain unclear.
Xiaogang Ge   +5 more
doaj   +3 more sources

Integrated single cell and bulk sequencing analysis identifies tumor reactive CXCR6+ CD8 T cells as a predictor of immune infiltration and immunotherapy outcomes in hepatocellular carcinoma

open access: yesFrontiers in Oncology, 2023
BackgroundVarious immune cell types in the tumor microenvironment (TME) of hepatocellular carcinoma (HCC) have been identified as important parameters associated with prognosis and responsiveness to immunotherapy.
Xiaogang Li   +32 more
doaj   +1 more source

Development of an Immune-Related Gene Signature for Prognosis in Melanoma

open access: yesFrontiers in Oncology, 2021
Melanoma remains a potentially deadly malignant tumor. The incidence of melanoma continues to rise. Immunotherapy has become a new treatment method and is widely used in a variety of tumors. Original melanoma data were downloaded from TCGA.
Jia-An Zhang   +6 more
doaj   +1 more source

Immune infiltrating cells in duodenal cancers [PDF]

open access: yesJournal of Translational Medicine, 2020
Abstract Background Duodenal adenocarcinoma (DA) is a rare yet aggressive malignancy, with increasing incidence in the last decades. Its low frequency has hampered a thorough understanding of the pathogenesis of the disease and of its biology, limiting the identification of tailored therapeutic options.
Donisi   +20 more
openaire   +3 more sources

Construction and validation of an immune infiltration-related risk model for predicting prognosis and immunotherapy response in low grade glioma

open access: yesBMC Cancer, 2023
Background Low grade glioma (LGG) is considered a heterogeneous tumor with highly variable survival and limited efficacy of immunotherapy. To identify high-risk subsets and apply immunotherapy effectively in LGG, the status and function of immune ...
Jinna Li, Qing Guo, Rui Xing
doaj   +1 more source

Keloid Biomarkers and Their Correlation With Immune Infiltration

open access: yesFrontiers in Genetics, 2022
Objective: This work aimed to verify the candidate biomarkers for keloid disorder (KD), and analyze the role of immune cell infiltration (ICI) in the pathology of keloid disorder.Methods: The keloid-related datasets (GSE44270 and GSE145725) were retrieved from the Gene Expression Omnibus (GEO).
Xufeng Yin   +4 more
openaire   +3 more sources

Combined PD-1/PD-L1 and tumor-infiltrating immune cells redefined a unique molecular subtype of high-grade serous ovarian carcinoma

open access: yesBMC Genomics, 2022
Background High-grade serous ovarian carcinoma is highly heterogeneous, and although many studies have been conducted to identify high-grade serous ovarian carcinoma molecular subtypes that are sensitive to immunotherapy, no precise molecular subtype has
Ping Liu   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy